-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Crohn's disease (CD) and ulcerative colitis (UC) are a complex group of inflammatory bowel diseases (IBD) with major symptoms including fistulas, perforations, malnutrition, and intestinal obstruction
Crohn's disease (CD) and ulcerative colitis (UC) are a complex group of inflammatory bowel diseases (IBD) with major symptoms including fistulas, perforations, malnutrition, and intestinal obstruction
This retrospective study included adults with mild-to-moderate IBD who started thiopurines without biological therapy
Of the 230 CD patients, 64 (72%) had no treatment failure with a mean follow-up of 3.
Figure: Time chart of patient relapse
This study demonstrates that thiopurine monotherapy is associated with clinical disease maintenance in remission in mild-to-moderate uncomplicated IBD, and that thiopurine monotherapy may represent a lower cost, convenient and effective alternative to biologics
This study demonstrates that thiopurine monotherapy is associated with clinical disease maintenance in remission in mild-to-moderate uncomplicated IBD, and that thiopurine monotherapy may represent a lower cost, convenient and effective alternative to biologics
Original source:
Grant E.
Grant E.
Barber.
Et al.
Thiopurine Monotherapy Is Effective in Maintenance of Mild-Moderate Inflammatory Bowel Disease.
Digestive Diseases and Sciences.
2022.
Thiopurine Monotherapy Is Effective in Maintenance of Mild-Moderate Inflammatory Bowel Disease.
Leave a Comment
